Background: Infectious diseases and vaccines can occasionally cause new-onset or flare of
immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 …

Herein, we consider venous immunothrombotic mechanisms in SARS-CoV-2 infection and
anti-SARS-CoV-2 DNA vaccination. Primary SARS-CoV-2 infection with systemic viral RNA …

Objective. To identify the clinical features that can help to distinguish between psoriatic
arthritis (PsA) and fibromyalgia (FM). Methods. Our cross-sectional study was carried out in 10 …

The recognition of the primacy of enthesitis in animal models of spondyloarthritis and the
prevalence of clinically occult enthesopathy in psoriatic subjects and of persistent joint pain in …

Objectives Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …

Objectives To update the EULAR points to consider (PtCs) on the use of immunomodulatory
therapies in COVID-19. Methods According to the EULAR standardised operating …

Objective To summarise the available information on efficacy and safety of immunomodulatory
agents in SARS-CoV-2 infection. Methods As part of a European League Against …

The SARS-CoV-2 virus ACE-2 receptor utilization for cellular entry and the defined ACE-2
receptor role in cardiovascular medicine hinted at dysregulated endothelial function or even …

Background The transition from psoriasis (PsO) to psoriatic arthritis (PsA) and the early
diagnosis of PsA is of considerable scientific and clinical interest for the prevention and …

Objectives To systematically review the evidence for a synergistic effect of combining
rehabilitation with biological anti-tumour necrosis factor (TNF) therapy in patients with ankylosing …